Related Experiment Video
Updated: Jul 18, 2025
08:34
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
20.4K
Radiotherapy management of paediatric cancers with synchronous metastasis
L Claude1, J Bouter2, G Le Quellenec3
1Service de radiothérapie, centre Léon-Bérard, 28, rue Laennec, 69008 Lyon, France.
Summary
Pediatric radiation therapy for synchronous metastatic cancers is rare but improving. This article synthesizes radiotherapy management for common childhood cancers with metastasis.
Area of Science:
- Pediatric Oncology
- Radiation Oncology
- Medical Oncology
Background:
- Childhood cancers account for 1% of all new cancer diagnoses.
- Approximately 30% of pediatric cancer patients (600-700 annually in France) receive radiation therapy.
- Paediatric cancers with synchronous metastasis are rare, often associated with a poor standard of care.
Framework:
- This article synthesizes radiotherapy management strategies.
- Focuses on both primary tumors and synchronous metastases.
- Addresses the most common childhood and adolescent cancers.
Implementation:
- Considers the unique challenges of treating rare metastatic paediatric cancers.
- Highlights efforts by paediatric oncology societies to establish treatment consensus and trials.
- Aims to provide a unified approach to radiotherapy in these complex cases.
Implications:
- Aims to improve the standard of care for paediatric cancers with synchronous metastasis.
- Offers a valuable resource for clinicians managing these rare oncological conditions.
- Contributes to advancing treatment protocols in paediatric radiation oncology.
Related Concept Videos
02:49Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K